Comparison of the effects of the intranigral injections of cholinomimetics with systemic injections of the dopamine receptor stimulating and blocking agents in the rabbit.
D000109:Acetylcholine / Q000494:pharmacology; D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D003864:Depression, Chemical; D004567:Electrodes, Implanted; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects; D006801:Humans; D007267:Injections; D008124:Locomotion / Q000187:drug effects; D008688:Methacholine Compounds / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D011950:Receptors, Cholinergic / Q000187:drug effects*; D013150:Spirostans / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013268:Stimulation, Chemical; D013378:Substantia Nigra; D013997:Time Factors
D008688:Methacholine Compounds; D010277:Parasympathomimetics; D011950:Receptors, Cholinergic; D013150:Spirostans; D009388:Neostigmine; D001285:Atropine; D000547:Amantadine; D001058:Apomorphine; D000109:Acetylcholine